Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers
PHASE4CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
May 31, 2004
Primary Completion Date
November 30, 2005
Study Completion Date
November 30, 2005
Conditions
MigraineSinusitis
Interventions
DRUG
almotriptan or pseudoephedrine
Trial Locations (1)
65807
Clinvest, Inc., Springfield
All Listed Sponsors
collaborator
Ortho-McNeil Neurologics, Inc.
INDUSTRY
lead
Clinvest
OTHER
NCT00208065 - Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers | Biotech Hunter | Biotech Hunter